Didanosine

去羟肌苷

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameDidanosine
Drug Alias NameMegavir双脱氧胞甙Didanosinum地达诺新Deoxyinosine +[17] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsAIDS-Related ComplexAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1991/10/09
Country/TerritoryUnited StatesPuerto RicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaResearch Co LtdBristol Myers Squibb SrlcompanyNational Cancer Institute +[5] 
Active IndicationsHIV Infections
Inactive IndicationsAIDS-Related ComplexAcquired Immunodeficiency Syndrome

Other Information

ATC CodeJ05AF02
Related LinksWikipediaDrugBankKEGG